In connection with the Leo Pharma’s annual report on Thursday, the company has gone through a reshuffling of its board of directors, including saying goodbye to Vice Chair Anders Ekblom, who has been at the firm for four years.
by ANDREAS LØNSTRUP, translated by daniel pedersen
Leo Pharma’s Vice Chair Anders Ekblom and Board Member Birgitta Stymne Göransson have both stepped down from the company’s board of directors, according to the Danish Central Business Register (CVR) and confirmed by Leo Pharma on Thursday.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.